Rising Pharmaceuticals is a key player in the Biotechnology and Pharmaceutical industries, with a focus on marketing and distributing generic prescription pharmaceutical products. Established in 2019 and headquartered in the United States, the company prides itself on its extensive range of commercial products spanning various therapeutic areas and multiple dosage forms. Additionally, they have a robust emerging pipeline of pharmaceutical products through the development of Abbreviated New Drug Applications (ANDA) filed, or in the process of being filed, with the FDA. Rising Pharmaceuticals' commitment to providing high-quality pharmaceuticals is evident through their state-of-the-art, FDA approved manufacturing facilities and the implementation of quality assurance techniques that meet regulatory standards. The company's strong emphasis on customer partnerships throughout the United States ensures the safe and effective delivery of their products to the public. With a leading management team comprising industry experts, Rising Pharmaceuticals is dedicated to continued innovation in drug development, marketing, and distribution. Their goal is to remain at the forefront of the industry by staying committed to high-quality standards and fostering ongoing advancements in their products and services.
There is no investment information
No recent news or press coverage available for Rising Pharmaceuticals.